Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study

被引:0
|
作者
Jong Hyun Tae
Moon Soo Ha
Byung Hoon Chi
In Ho Chang
Tae-Hyoung Kim
Soon Chul Myung
Tuan Thanh Nguyen
Myoungsuk Kim
Kyung-Eun Lee
Yuwon Kim
Hyun-ki Woo
Dae-Sung Kyoung
Hasung Kim
Se Young Choi
机构
[1] Chung-Ang University Hospital,Department of Urology
[2] Chung-Ang University College of Medicine,Department of Urology
[3] Hyundae General Hospital,Department of Urology, Cho Ray Hospital
[4] Chung-Ang University College of Medicine,Data Science Team
[5] University of Medicine and Pharmacy at Ho Chi,Data Science Team
[6] Evidnet. Co.,undefined
[7] Ltd,undefined
[8] Hanmi Pharm. Co.,undefined
[9] Ltd,undefined
来源
BMC Urology | / 22卷
关键词
Drug therapy; Ureteral neoplasms; Survival; Chemotherapy; Population;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Neoadjuvant combined chemotherapy and immunotherapy for upper tract urothelial carcinoma: Preliminary results of a phase II study
    Bi, X.
    Shou, J.
    Zhou, A.
    Zhang, W.
    Cao, C.
    Lu, L.
    Wen, L.
    Guan, Y.
    Shi, H.
    Xiao, Z.
    Jiang, Z.
    Sun, Y.
    Zheng, S.
    Zhang, J.
    EUROPEAN UROLOGY, 2022, 81 : S469 - S469
  • [42] RESPONSE TO NEOADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA-AN UPPER TRACT COLLABORATIVE NETWORK (UCAN) STUDY
    Yu, Alice
    Hensley, Patrick J.
    Huelster, Heather L.
    Martin, Austin
    Pham, Jonathan
    Pallauf, Maximilian
    Katims, Andrew
    Potrezke, Aaron
    Raman, Jay D.
    Singla, Nirmish
    Margulis, Vitaly
    Coleman, Jonathan
    Matin, Surena F.
    Spiess, Philippe E.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E449 - E450
  • [43] SURVIVAL OUTCOMES IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY FOR UPPER TRACT UROTHELIAL CELL CARCINOMA
    Porten, Sima
    Siefker-Radtke, Arlene
    Kamat, Ashish
    Dinney, Colin
    Matin, Surena
    JOURNAL OF UROLOGY, 2013, 189 (04): : E366 - E367
  • [44] Utilization of neoadjuvant chemotherapy (NAC) and pathologic outcomes in upper tract urothelial carcinoma (UTUC)
    Xu, Vincent Eric
    Azari, Sarah
    Klein, Matthew Nicholas
    Drouaud, Arthur
    Chang, Phat
    Antar, Ryan Michael
    Gordon, Olivia French
    Smith, Armine
    Whalen, Michael Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] TRENDS IN UTILIZATION OF NEOADJUVANT CHEMOTHERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA IN THE NATIONAL CANCER DATABASE
    Bahler, Clinton
    Monn, Francesca
    Sundaram, Chandru
    JOURNAL OF UROLOGY, 2016, 195 (04): : E24 - E24
  • [46] Pathological downstaging as a novel endpoint for the development of neoadjuvant chemotherapy for upper tract urothelial carcinoma
    Martini, Alberto
    Daza, Jorge
    Poltiyelova, Elona
    Gul, Zeynep
    Heard, John R.
    Ferket, Bart S.
    Waingankar, Nikhil
    Galsky, Matthew D.
    Sfakianos, John P.
    BJU INTERNATIONAL, 2019, 124 (04) : 665 - 671
  • [47] TWO CYCLES OF NEOADJUVANT CHEMOTHERAPY IMPROVES SURVIVAL OF UPPER TRACT UROTHELIAL CARCINOMA PATIENTS
    Zennami, Kenji
    Takahara, Kiyoshi
    Fukaya, Kosuke
    Ichino, Manabu
    Fukami, Naohiko
    Sasaki, Hitomi
    Sumitomo, Makoto
    Kusaka, Mamoru
    Shiroki, Ryoichi
    JOURNAL OF UROLOGY, 2020, 203 : E1248 - E1249
  • [48] Survival outcomes in patients undergoing neoadjuvant chemotherapy for upper tract urothelial cell carcinoma
    Porten, Sima P.
    Siefker-Radtke, Arlene O.
    Kamat, Ashish M.
    Dinney, Colin P. N.
    Matin, Surena F.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [49] Re: Comparative Effectiveness of Neoadjuvant Chemotherapy in Bladder and Upper Urinary Tract Urothelial Carcinoma
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2022, 207 (06): : 1346 - 1347
  • [50] Carcinoma Following Neoadjuvant Chemotherapy Oncologic Outcomes in Patients with Residual Upper Tract Urothelial
    Fletcher, Sean A.
    Pallauf, Maximilian
    Watts, Emelia K.
    Lombardo, Kara A.
    Campbell, Jack A.
    Rezaee, Michael E.
    Roupret, Morgan
    Boorjian, Stephen A.
    Potretzke, Aaron M.
    Roshandel, M. Reza
    Ploussard, Guillaume
    Djaladat, Hooman
    Ghoreifi, Alireza
    Mari, Andrea
    Campi, Riccardo
    Khene, Zine-Eddine
    Raman, Jay D.
    Kikuchi, Eiji
    Rink, Michael
    Abdollah, Firas
    Boormans, Joost L.
    Fujita, Kazutoshi
    D'Andrea, David
    Soria, Francesco
    Breda, Alberto
    Hoffman-Censits, Jean
    Mcconkey, David J.
    Shariat, Shahrokh F.
    Pradere, Benjamin
    Singla, Nirmish
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (05): : 1061 - 1068